US · Healthcare · Medical Devices
EPS came in at 11.00 against a street estimate of -8.60 — a beat of 227.9%.
Analysts rate Beyond Air Inc a buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $20.00.
| Fund | Stake |
|---|---|
| Balyasny Asset Management LLC | 2.36% |
| Murchinson Ltd. | 1.68% |
| Geode Capital Management, LLC | 0.81% |
| Daytona Street Capital LLC | 0.77% |
| Bleichroeder LP | 0.44% |
| Vanguard Capital Management, LLC | 0.16% |
| Vanguard Fiduciary Trust Co | 0.15% |
| Jane Street Group LLC | 0.14% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Beyond Air Inc — free to start.
Google PlayApp StoreData updated 2026-09-18.